Eton Pharmaceuticals shares rise on Q2 results, FY26 revenue guidance
Eton Pharmaceuticals is up after reporting better-than-expected Q2 financial results and issuing FY26 revenue guidance above estimates,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.